Morgan Stanley Maintains Overweight on KLA, Lowers Price Target to $227

Benzinga Newsdesk www.benzinga.com Negative 90.1%

Neg 90.1% Neu 0% Pos 0%

Morgan Stanley analyst Shane Brett maintains KLA (NASDAQ:KLAC) with a Overweight and lowers the price target from $253 to $227.